From the post:
In collaboration with AstraZeneca, Bristol-Myers Squibb, DuPont and Pfizer, IBM is providing a database of more than 2.4 million chemical compounds extracted from about 4.7 million patents and 11 million biomedical journal abstracts from 1976 to 2000. The announcement was made at an IBM forum on U.S. economic competitiveness in the 21st century, exploring how private sector innovations and investment can be more easily shared in the public domain.
Excellent news and kudos to IBM and its partners for making the information available!
Now it is up to you to find creative ways to explore, connect up, analyze the data across other information sets.
My first question would be what was mentioned besides chemicals in the biomedical journal abstracts? Care to make an association to represent that relationship?
Why? Well, for example, if you are exposed to raw benzene, a by product of oil refining, it can produce symptoms that are nearly identical to leukemia. Where would you encounter such a substance? Well, try living in Nicaragua for more than a decade and every day the floors are cleaned with raw benzene. Of course, in the States, doctors don’t check for exposure to banned substances. Cases like that.
BTW, the data is already up, see: PubChem. Follow the links to the interface and click on “structures.” Not my area but the chemical structures are interesting enough that I may have to get a chemistry book for Christmas so I can have some understanding of what I am seeing.
That is probably the best part of being interested in semantic integration is that it cuts across all fields and new discoveries await with every turn of the page.
[…] journal abstracts from 1976 to 2000. The announcement was made at an IBM forum on U….. Share this:TwitterFacebookLike this:LikeBe the first to like this […]
Pingback by Savanna Story — January 1, 2012 @ 11:52 am